TY  - GEN
AU  - Rodríguez-Agustín, Andrea
AU  - Casanova, Víctor
AU  - Grau-Expósito, Judith
AU  - Sánchez-Palomino, Sonsoles
AU  - Alcamí, José
AU  - Climent, Núria
PY  - 2023
DO  - 10.3390/pharmaceutics15030917
SN  - 1999-4923
UR  - http://hdl.handle.net/20.500.12105/16835
AB  - Tyrosine kinase inhibitors (TKIs) have been extensively used as a treatment for chronic myeloid leukemia (CML). Dasatinib is a broad-spectrum TKI with off-target effects that give it an immunomodulatory capacity resulting in increased innate immune...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - Dasatinib
KW  - Tyrosine kinase inhibitors
KW  - CML
KW  - Cancer
KW  - HIV-1
KW  - CMV
KW  - HIV functional cure
KW  - Memory-like NK cells
KW  - γδ T cells
KW  - Anti-aging
KW  - Senolytic
TI  - Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging
TY  - review article
ER  -